Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Miris Holding

38.49 SEK

-0.54 %

Less than 1K followers

MIR

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Miris Holding

2019202020212022202320242025
Revenue11.810.815.218.715.517.617.5
growth-%-8.2 %41.3 %22.4 %-17.1 %13.5 %-0.5 %
EBITDA-18.7-9.7-9.6-7.9-10.1-4.8-4.0
EBIT-21.9-13.1-13.0-11.3-13.1-5.3-4.0
Profit before taxes-22.6-13.4-13.4-11.4-13.8-6.3-4.8
Net income-22.6-13.4-13.4-11.4-13.8-6.3-4.8
EPS-744.68-324.61-208.41-117.50-126.27-25.04-0.02
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-159.3 %-90.4 %-63.0 %-42.2 %-65.3 %-27.1 %-22.8 %
EBIT-%-186.7 %-121.7 %-85.3 %-60.4 %-84.9 %-30.1 %-22.8 %
ROE-141.8 %-743.0 %-79.1 %-96.8 %691.0 %-231.0 %-23.9 %
ROI-68.8 %-67.5 %-46.7 %-53.2 %-66.9 %-28.2 %-15.9 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.